Breaking News Instant updates and real-time market news.

GWPH

GW Pharmaceuticals

$164.42

-3.22 (-1.92%)

05:15
04/16/19
04/16
05:15
04/16/19
05:15

GW Pharmaceuticals shares can rally 15% on imminent data, says Piper Jaffray

The pivotal Phase 3 data with epidiolex for seizures related to tuberous sclerosis complex are imminent, yet it's hard to gauge how much investors care, Piper Jaffray analyst Danielle Brill tells investors in a research note. The analyst models a 50% probability of success for tuberous sclerosis complex and sees ~15% share upside if the data support label expansion. However, Brill adds that if safety looks clean and higher doses drive better efficacy, peak sales could be double her $400M estimate, driving potential upside of 20%-25%. If efficacy and/or safety signals occur that prevent label expansion for tuberous sclerosis complex, she estimates share downside of ~15%. This could be "substantially more" with a severe safety signal that broadly prohibits off-label use, however, the analyst adds. Brill has an Overweight rating on GW Pharmaceuticals with a $185 price target.

GWPH GW Pharmaceuticals
$164.42

-3.22 (-1.92%)

02/26/19
PIPR
02/26/19
NO CHANGE
PIPR
GW metrics indicate 'hugely successful' Epidiolex launch, says Piper Jaffray
Piper Jaffray analyst Danielle Brill says GW Pharmaceuticals' Epidiolex revenues of $4.7M for the first quarter of commercial launch beat her $3.7M and consensus $2.5M estimate. While these numbers "solidly beat expectations," they are still not truly representative of Epidiolex's launch trajectory, Brill tells investors in a post-earnings research note titled "Epidiolex Metrics Signify a Hugely Successful Launch." She notes that Q4 was a stub quarter, as Eepidiolex launched in early November, which included two holiday weeks and that refill rates were likely very low due to protracted initial turnaround times. The analyst expects to see "significant" revenue growth in the coming quarters. She has an Overweight rating on GW Pharmaceuticals, which is trading up 8.1%, or $12.41, to $165.30 following the earnings report.
02/27/19
PIPR
02/27/19
NO CHANGE
Target $185
PIPR
Overweight
GW Pharmaceuticals price target raised to $185 from $180 at Piper Jaffray
Piper Jaffray analyst Danielle Brill raised her price target for GW Pharmaceuticals to $185 saying the Epidiolex launch is off to a "very strong start" and still gaining momentum. Management commentary indicates the launch is "living up to the hype," Brill tells investors in a post-earnings research note. Further, she believes GW has the infrastructure in place to meet high demand. The analyst reiterates an Overweight rating on the shares.
03/04/19
PIPR
03/04/19
NO CHANGE
PIPR
Piper Jaffray sees continued medical cannabis growth
Piper Jaffray analyst Michael Lavery writes that his discussions with a medical pain specialist in New York affirm his expectations of continued growth for medical cannabis, particularly as practitioners search for opioid alternatives. With over 30 U.S. states now in favor of medical use of marijuana, the analyst believes that the national prohibition will end in the next few years with the "STATES Act or federal legalization". Lavery is positive on Tilray (TLRY) and its partnership with Novartis (NVS) to develop and distribute medical cannabis products, keeping his Overweight rating and $90 price target on the shares. The analyst also calls GW Pharma (GWPH) a "trailblazer for developing cannabis-derived products for medical use", with its FDA-approved epidiolex cannabidiol product, keeping his Overweight rating and $195 price target on the stock. Lavery further maintains his Overweight rating and $60 price target on Canopy Growth (CGC) given its current valuation.
04/09/19
MSCO
04/09/19
NO CHANGE
Target $227
MSCO
Overweight
GW Pharma shares should rise 5%-10% on Zogenix delay, says Morgan Stanley
Morgan Stanley analyst David Lebowitz said he expects shares of GW Pharmaceuticals (GWPH) to be up at least 5-10% on the open following news that Zogenix (ZGNX) was issued a Refusal to File letter for Fintepla by the FDA. The RTF delays a potential competing product for Epidiolex for the treatment of seizures associated with Dravet Syndrome, Lebowitz explained. While he lacks visibility, Lebowitz said he would expect a delay of 3-6 months on the short end if Zogenix can use historic toxicity data and a delay of up to 15 months if the FDA requires new toxicity studies. Lebowitz keeps an Overweight rating on GW Pharmaceuticals shares, which are up 4% to $174.85 in pre-market trading.

TODAY'S FREE FLY STORIES

NWL

Newell Brands

$13.84

-0.4 (-2.81%)

11:55
04/25/19
04/25
11:55
04/25/19
11:55
Options
Newell Brands put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    May

  • 07

    May

  • 14

    May

  • 15

    May

  • 16

    May

  • 17

    May

11:50
04/25/19
04/25
11:50
04/25/19
11:50
General news
U.S. Treasury tax receipts continue to surge »

U.S. Treasury tax…

GILD

Gilead

$63.57

0.75 (1.19%)

11:48
04/25/19
04/25
11:48
04/25/19
11:48
Recommendations
Gilead analyst commentary at Piper Jaffray »

Piper Jaffray 'not…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Apr

  • 02

    May

  • 03

    May

  • 06

    May

  • 08

    May

  • 18

    May

IMMR

Immersion

$9.27

0.03 (0.32%)

11:45
04/25/19
04/25
11:45
04/25/19
11:45
Options
Immersion call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

11:45
04/25/19
04/25
11:45
04/25/19
11:45
General news
Treasury's $85 B 4- and 8-week bill auctions were mixed »

Treasury's $85 B 4-…

11:43
04/25/19
04/25
11:43
04/25/19
11:43
General news
8-Week Bill Auction Total Amount data reported »

8-Week Bill Auction Total…

11:43
04/25/19
04/25
11:43
04/25/19
11:43
General news
4-Week Bill Auction Total Amount data reported »

4-Week Bill Auction Total…

FB

Facebook

$193.51

10.87 (5.95%)

, TSLA

Tesla

$251.50

-7.2 (-2.78%)

11:38
04/25/19
04/25
11:38
04/25/19
11:38
On The Fly
Facebook upgrade, Tesla downgrade among today's top calls »

Check out today's top…

FB

Facebook

$193.51

10.87 (5.95%)

TSLA

Tesla

$251.50

-7.2 (-2.78%)

PTC

PTC

$90.78

-11.16 (-10.95%)

XLNX

Xilinx

$116.64

-23.15 (-16.56%)

GD

General Dynamics

$178.46

-2.21 (-1.22%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Apr

  • 01

    May

  • 14

    May

  • 29

    May

  • 30

    May

  • 03

    Jun

PAGS

PagSeguro Digital

$26.34

-0.14 (-0.53%)

11:35
04/25/19
04/25
11:35
04/25/19
11:35
Options
PagSeguro Digital put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    May

ZAYO

Zayo Group

$30.67

-1.075 (-3.39%)

11:31
04/25/19
04/25
11:31
04/25/19
11:31
Recommendations
Zayo Group analyst commentary at Wells Fargo »

Zayo weakness due to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    May

CGI

Symbol changed to CGIP

$0.00

(0.00%)

, CGIP

Celadon Group

$0.00

(0.00%)

11:26
04/25/19
04/25
11:26
04/25/19
11:26
Hot Stocks
Celadon Group announces resolutions of DOJ, SEC investigations »

Celadon Group announced…

CGI

Symbol changed to CGIP

$0.00

(0.00%)

CGIP

Celadon Group

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LBTYK

Liberty Global

$26.04

-0.35 (-1.33%)

11:25
04/25/19
04/25
11:25
04/25/19
11:25
Options
Liberty Global call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    May

WABC

Westamerica

$62.57

-0.87 (-1.37%)

11:21
04/25/19
04/25
11:21
04/25/19
11:21
Hot Stocks
Westamerica increases quarterly cash dividend to 41c from 40c per share »

The board of directors of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

11:20
04/25/19
04/25
11:20
04/25/19
11:20
General news
Energy Action: RBOB gasoline futures »

Energy Action: RBOB…

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

11:17
04/25/19
04/25
11:17
04/25/19
11:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

11:16
04/25/19
04/25
11:16
04/25/19
11:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

11:15
04/25/19
04/25
11:15
04/25/19
11:15
General news
Treasury announced $75 B in 3- and 6-month bill auctions for Monday »

Treasury announced $75 B…

11:15
04/25/19
04/25
11:15
04/25/19
11:15
General news
Breaking General news story  »

8-Week Bill Auction to be…

11:15
04/25/19
04/25
11:15
04/25/19
11:15
General news
Breaking General news story  »

4-Week Bill Auction to be…

APC

Anadarko

$71.51

0.1 (0.14%)

11:10
04/25/19
04/25
11:10
04/25/19
11:10
Options
Bullish three-way spread in Anadarko targets an 8% move »

Bullish three-way spread…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    May

  • 22

    May

11:09
04/25/19
04/25
11:09
04/25/19
11:09
General news
6-Month Bill Announcement Offering Amount data reported »

6-Month Bill Announcement…

11:09
04/25/19
04/25
11:09
04/25/19
11:09
General news
3-Month Bill Announcement Offering Amount data reported »

3-Month Bill Announcement…

CGI

Symbol changed to CGIP

$0.00

(0.00%)

11:06
04/25/19
04/25
11:06
04/25/19
11:06
Hot Stocks
SEC charges Celadon Group with accounting fraud »

The Securities and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

T

AT&T

$30.27

-0.51 (-1.66%)

, DIS

Disney

$135.26

0.16 (0.12%)

11:04
04/25/19
04/25
11:04
04/25/19
11:04
Periodicals
Disney in talks to buy Comcast's 30% stake in Hulu, CNBC reports »

Disney (DIS) is in talks…

T

AT&T

$30.27

-0.51 (-1.66%)

DIS

Disney

$135.26

0.16 (0.12%)

CMCSK

Comcast

$0.00

(0.00%)

CMCSA

Comcast

$43.75

1.88 (4.49%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 26

    Apr

  • 28

    Apr

  • 06

    May

  • 07

    May

  • 08

    May

  • 18

    May

  • 20

    May

  • 24

    Jul

11:03
04/25/19
04/25
11:03
04/25/19
11:03
General news
Kansas City Fed Manufacturing Index Level data reported »

April Kansas City Fed…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.